Associate Principal Scientist
Merck & Co., Inc.
Dong Hun (Don) Lee, Associate Principal Scientist at Merck, has 16 years of LBA based bioanalysis of biotherapeutics experience including PK, ADA, TE, cell-based NAb assays. Highlights of his Merck career include contributions to three FDA approved Merck drugs: Keytruda (pembrolizumab), Zinplava (bezlotoxumab), and Bridion (Sugammadex).
Don received a BS at Kyung-Book National University in Korea, a MS at State University of New York in Syracuse, New York and a PhD in Biomedical Sciences from University of Amsterdam, Netherlands.